ESMA has published a document addressing queries from competent authorities on the implementation of EMIR which may prove useful to investors and market participations in clarifying the requirements under the regulation. The document answers a significant number of questions relating to OTC derivatives, central counterparties, trade repositories and around reporting obligations.